1 Roche 2013 results London‚ 30 January 2014 2 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by words such as ‘believes’‚ ‘expects’‚ ‘anticipates’‚ ‘projects’‚ ‘intends’‚ ‘should’‚ ‘seeks’‚ ‘estimates’‚ ‘future’ or similar expressions or by discussion of‚ among other things‚ strategy‚ goals‚ plans or intentions. Various factors may cause actual results to differ materially in the future from those reflected in forward-looking
Premium Cancer Oncology Tumor
the dismal prognoses of a majority of cancer patients. Thus‚ as an alternative to treatments designed only to kill cancer cells‚ researchers must today focus on developing the means to reduce or even to prevent the migration of these cells14. * Tumor-cell invasion and migration. The process of tumour-cell invasion and metastasis is conventionally understood as the migration of individual cells that detach from the primary tumour‚ enter lymphatic vessels or the bloodstream and seed in distant
Premium Cancer Oncology Signal transduction
Patients treated surgically are elevated for risk factors for metastatic disease and tumor recurrence. These include metastatic disease to the lymph nodes‚ tumor size >4 cm‚ poorly differentiated lesions‚ or positive‚ margins. Patients with these findings are offered adjuvant therapy (radiation therapy and chemotherapy). • Specific by stage: Stage Ia1: Total simple hysterectomy
Premium Cancer Oncology Breast cancer
Infantile hemangiomas (IHs)‚ which are characterized by endothelial cell hyperproliferation‚ are the most common soft tissue tumors of infancy. They occur in 4% to 10% of children younger than one year of age. Females are affected more often than males with ratio of 3:1 [1-2]. Prematurity and low birth weight (<1500 grams) are considered potential predisposing factors. Infantile hemangiomas are characterised by a triphasic clinical and histological evolution with rapid growth (proliferative phase)
Premium Cancer Oncology Childbirth
people in the united states alone develop a brain tumor. With a survival rate of only 5.1 percent many doctors and scientists are trying very hard to help treat brain tumors. With no no reason behind why they form‚ brain tumors continue to be a very big threat in today’s society. In my research paper i will discuss the ins and outs about what brain tumors are and what people are doing to stop the disease the kills thousands every year. A brain tumor is formed in the brain and affects the majority
Premium Cancer Oncology Chemotherapy
Introduction • Bone tumor is neoplastic growth of tissue in bone‚ abnormal growth can benign or malignant. • Average five year survival in united states after being diagnosed with bone & joint cancer is 67%. CLASSIFICATION Tumor classified as primary tumors‚ which originate in bone derived cells & tissues.it may be neoplastic‚ developmental‚ traumatic‚ infectious & inflammatory etiology. Secondary tumors originate in other sites & spread (metastasizes) to skeleton. Carcinomas of prostate‚
Premium Cancer
Wilms Tumor Wilms tumor‚ also called Nephroblastoma‚ is the most common type of pediatric kidney cancer‚ accounting for about 5% of all childhood cancers. “It is named after Max Wilms‚ a German doctor who wrote one of the first medical articles about the disease in 1899” (The American Cancer Society‚ 2016). Majority of cases are diagnosed before the age of 5‚ becoming less common as the child grows older. There are approximately 500 new cases diagnosed every year in the United States. During
Premium Cancer Cancer staging Oncology
Children with a suspected or diagnosed Wilms tumor should be immediately referred to a pediatric cancer specialist for evaluation and treatment. Children have an overall five-year survival rate of 90%. As similarly mentioned in the diagnostic protocol for Wilms tumor‚ the COG and SIOP each have their own treatment protocols. Both protocols have statistically similar clinical outcomes‚ however‚ the focus for this section will follow the COG protocol. The COG protocol is advantageous in promoting
Premium Cancer Chemotherapy Oncology
REPORT AND REVIEW OF LITERATURE ABSTRACT INTRODUCTION Central Giant Cell Granuloma also termed as Reparative Giant Cell Granuloma is an uncommon benign intraosseous lesion. It was first introduced by Jaffe in 1953 to distinguish it from Giant Cell Tumor of bone. World Health Organization has defined it as an intraosseous lesion consisting of cellular fibrous tissue with multiple hemmorhagic foci‚ aggregations of multinucleated giant cells and occasionally trabeculae of woven bone. CGCG accounts for
Premium Cancer Oncology Bone marrow
Mucinous cystic neoplasms (MCN) are a group of rare pancreatic lesions that include benign cystadenomas and malignant cystadenocarcinomas. Middle aged women are almost exclusively affected‚ with a female to male predominance of 20:1 and an average age of diagnosis of 50. Affected individuals are frequently asymptomatic and lesions are discovered incidentally. Few present with nonspecific symptoms‚ such as abdominal pain‚ or sequelae of metastatic spread. Wide-spread availability and improved resolution
Premium Cancer Oncology Cancer staging